Entities / Company
Neumora Therapeutics, Inc..
biopharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 10
What's happening
Gone quiet
No new reports in 90+ days-
Mizuho analysts raised their price target for Neumora Therapeutics, Inc. on July 20, 2025.Some support1 report
-
Amgen Inc. is reported as the largest shareholder of Neumora Therapeutics, Inc.Speculative1 report
-
Christoph Correll discussed Neumora Therapeutics' promising M4 receptor targeting approach and scientific ties in Germany.Speculative1 report
-
Neumora Therapeutics, Inc. announced it will participate in a conference in Boston on September 3, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
History
Events by the month they beganJune 2026
4 events- Mizuho analysts raised their price target for Neumora Therapeutics, Inc. on July 20, 2025.
- Amgen Inc. is reported as the largest shareholder of Neumora Therapeutics, Inc.
- Christoph Correll discussed Neumora Therapeutics' promising M4 receptor targeting approach and scientific ties in Germany.
- Neumora Therapeutics, Inc. announced it will participate in a conference in Boston on September 3, 2025.